Open AccessPsychological stress and cardiovascular diseases.
Author(s) -
David Wheatley
Publication year - 1984
Publication title -
scandinavian journal of work, environment and health
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.621
H-Index - 103
eISSN - 1795-990X
pISSN - 0355-3140
DOI - 10.5271/sjweh.2319
Subject(s) - tranquilizer , placebo , coronary heart disease , medicine , myocardial infarction , psychopharmacology , disease , drug , psychiatry , alternative medicine , pathology
Mental stress may directly influence coronary heart disease (CHD) and also a number of its etiologic risk factors. Research work carried out by the Psychopharmacology Research Group in the United Kingdom indicates that antianxiety drugs may have an application in the management of the stress factors influencing CHD. In one study there was a significant reduction in the glyceryl trinitrate requirements of patients treated with a tranquilizer, but this result was not confirmed in two other studies. However, out of a total of 77 patients treated with a placebo, there were five cases of myocardial infarction during the trial periods as compared to no such cases among 81 patients treated with the antianxiety drugs.